Skip to content

Effect of Combined Intravenous-Inhalational Anesthesia (CIVIA) on Postoperative Recovery Patterns.

Effect of Combined Intravenous-Inhalational Anesthesia (CIVIA) on Postoperative Recovery Patterns.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07123870
Enrollment
210
Registered
2025-08-14
Start date
2025-07-23
Completion date
2025-11-15
Last updated
2026-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inhalation Anesthesia, Postoperative Recovery, Total Intravenous Anesthesia

Keywords

CIVIA, TIVA, sevoflurane, desflurane, postoperative recovery

Brief summary

This study was planned as a single-center, prospective, randomized trial. Adult patients undergoing elective spinal surgery lasting longer than three hours, performed in a neurosurgery operating room, will be evaluated. Patients managed with three different anesthesia methods currently used will be examined for recovery patterns: 1. Total intravenous anesthesia (TIVA), 2. TIVA Combined anesthesia with sevoflurane and intravenous agents (sevoflurane-CIVIA), 3. TIVA Combined anesthesia with desflurane and intravenous agents (desflurane-CIVIA). Recovery patterns include; extubation time, eye opening time, emergence agitation, postoperative nausia and vomiting and postoperative recovery unit discharge time.

Detailed description

The aim of this study was to compare the effects of different anesthesia methods applied in spinal surgeries lasting longer than three hours on postoperative recovery time. Specifically, it aimed to determine the contribution of low-dose (0.5 MAC) desflurane or sevoflurane combined intravenous anesthesia (CIVIA) approaches compared to total intravenous anesthesia (TIVA) on recovery parameters such as patient recovery time, extubation time, and time to consciousness. It also aimed to investigate whether the desflurane-containing combination resulted in a faster recovery than the sevoflurane-containing combination. TIVA will be administered using target-controlled infusion (TCI) with the Eleveld pharmacokinetic efect site model, utilizing a propofol-remifentanil combination, and guided by BIS monitoring. Outputs: Eye opening time (the time from the end of anesthesia until the patient's eye opening for verbal stimuli) Extubation time (the time from the end of anesthesia until extubation) Richardson agitation sedation and RAMSEY scale values, and Emergence agitation incidence. Postoperative nausea and vomiting incidence (PONV). Time to discharge from the PACU and time to an Aldrate score \>9 will be calculated.

Interventions

In this group of patients, \<0.5 MAC sevoflurane will be used in combination with TIVA. (TIVA method described above)

DRUGDesflurane

In this group of patients, \<0.5 MAC Desflurane will be used in combination with TIVA.

In this group, TIVA will be applied with the combination of BIS-guided propofol + remifentanil.

Sponsors

Kocaeli City Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Masking description

Participant: The participant will be unaware of which anesthesia method is involved in the perioperative period. Care Provider: The second anesthesiologist is responsible for the patient's recovery after the anesthesia is terminated and will be unaware of which anesthetic method was used.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Scheduled for spine surgery * Expected surgery duration longer than 3 hours * Use of intraoperative neuromonitoring * BIS-guided anesthesia administered * TIVA (with TCI) as the primary anesthetic technique * Age \>18 years

Exclusion criteria

* Emergency surgeries * Patients receiving sole inhaled anesthesia (no TIVA) * Perioperative dural injury * Intraoperative severe hypotension requiring inotropic support * Hypothermia (based on temperature measured before recovery)

Design outcomes

Primary

MeasureTime frameDescription
Extubation timeFirst postoperative hourExtubation time in patients after all anesthetic drugs have been discontinued

Secondary

MeasureTime frameDescription
Eye openingFirst postoperative hourtime brtween anesthesia terminated and aye opening after surgery

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORAhmet YUKSEK, Md

Kocaeli City Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 6, 2026